Fount Bio
Cambridge, US · Founded 2018 · Delaware corporation
Fount Bio is a life science company developing a pipeline of products for medical and beauty applications, combining bioorthogonal chemistry with glycopolymer science. It targets the aesthetics, consumer beauty, and medicine markets.
Founders & leadership
DL
Douglas LevinsonNamed on SEC filing
AA
Anthony AiudiNamed on SEC filing
SM
Samir MitragotriNamed on SEC filing
JB
Justin BurnsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2021
▶$8.2MraisedJul 2021 · 14 investors · OtherRule 506(b)
▶$8.2MraisedJul 2021 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Douglas LevinsonExecutive Officer, Director
- Anthony AiudiDirector
- Samir MitragotriDirector
- Justin BurnsDirector
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapIntuitive Biosciences4 shared keywordsIntuitive Bio develops immunoassays and diagnostic products and services, including non-human primate viral and TB tests and test processing, for research laboratories. The company offers assay development from proof of concept to fully-validated assays in a multiplex format supporting 1–100 markers per well.
Fauna Bio3 shared keywordsFauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans. The biotech company focuses on discovering novel therapeutics for human diseases based on evolutionary and genomic insights.
Octant Bio3 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Fortress Biotech3 shared keywordsFortress Biotech is a biopharmaceutical company that develops and commercializes pharmaceutical products, maintaining a pipeline of both revenue-generating commercial-stage products and development-stage drug candidates. It advances its products through partnerships within the pharmaceutical industry.
Companies competing with Fount Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Fount Bio do?
- Fount Bio is a life science company developing a pipeline of products for medical and beauty applications, combining bioorthogonal chemistry with glycopolymer science. It targets the aesthetics, consumer beauty, and medicine markets.
- How much funding has Fount Bio raised?
- Fount Bio has disclosed $8.2M raised across 1 round.
- Where is Fount Bio headquartered?
- Fount Bio is headquartered in Cambridge, US.